Dipal Doshi - Net Worth and Insider Trading
Dipal Doshi Net Worth
The estimated net worth of Dipal Doshi is at least $6 Million dollars as of 2024-11-05. Dipal Doshi is the CEO of Entrada Therapeutics Inc and owns about 334,475 shares of Entrada Therapeutics Inc (TRDA) stock worth over $6 Million. Dipal Doshi is also the SVP Strategy & Bus Dev of Amicus Therapeutics Inc and owns about 1,706 shares of Amicus Therapeutics Inc (FOLD) stock worth over $19,414. Details can be seen in Dipal Doshi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dipal Doshi has not made any transactions after 2024-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dipal Doshi
Dipal Doshi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dipal Doshi owns 2 companies in total, including Amicus Therapeutics Inc (FOLD) , and Entrada Therapeutics Inc (TRDA) .
Click here to see the complete history of Dipal Doshi’s form 4 insider trades.
Insider Ownership Summary of Dipal Doshi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2015-07-08 | SVP Business Planning & Dev |
| TRDA | Entrada Therapeutics Inc | 2024-07-15 | director & President and CEO |
Dipal Doshi Latest Holdings Summary
Dipal Doshi currently owns a total of 2 stocks. Among these stocks, Dipal Doshi owns 334,475 shares of Entrada Therapeutics Inc (TRDA) as of July 15, 2024, with a value of $6 Million and a weighting of 99.68%. Dipal Doshi also owns 1,706 shares of Amicus Therapeutics Inc (FOLD) as of July 8, 2015, with a value of $19,414 and a weighting of 0.32%.
Latest Holdings of Dipal Doshi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics Inc | 2024-07-15 | 334,475 | 17.86 | 5,972,051 |
| FOLD | Amicus Therapeutics Inc | 2015-07-08 | 1,706 | 11.38 | 19,414 |
Holding Weightings of Dipal Doshi
Dipal Doshi Form 4 Trading Tracker
According to the SEC Form 4 filings, Dipal Doshi has made a total of 26 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 0 buys and 26 sells. The most-recent trade in Entrada Therapeutics Inc is the sale of 1,900 shares on July 15, 2024, which brought Dipal Doshi around $33,896.
According to the SEC Form 4 filings, Dipal Doshi has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 6,250 shares on July 8, 2015, which brought Dipal Doshi around $86,688.
Insider Trading History of Dipal Doshi
- 1
Dipal Doshi Trading Performance
Dipal Doshi Ownership Network
Ownership Network List of Dipal Doshi
Ownership Network Relation of Dipal Doshi
Dipal Doshi Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Dipal Doshi is the SVP Business Planning & Dev of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, Dipal Doshi made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 333,235 shares made by John F Crowley , a net sale of 224,861 shares made by Bradley L Campbell , and a net sale of 95,000 shares made by Ellen Rosenberg .
In summary, during the past 3 months, insiders sold 22,500 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 22,500 shares. During the past 18 months, 795,880 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 795,880 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
Dipal Doshi Mailing Address
Above is the net worth, insider trading, and ownership report for Dipal Doshi. You might contact Dipal Doshi via mailing address: C/o Amicus Therapeutics, 1 Cedar Brook Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
